519 related articles for article (PubMed ID: 31486525)
1. Factors associated with spontaneous adverse drug reaction reporting among healthcare professionals in Vietnam.
Le TT; Nguyen TTH; Nguyen C; Tran NH; Tran LA; Nguyen TB; Nguyen N; Nguyen HA
J Clin Pharm Ther; 2020 Feb; 45(1):122-127. PubMed ID: 31486525
[TBL] [Abstract][Full Text] [Related]
2. Exploring the factors and barriers of healthcare professionals in tertiary care hospitals toward pharmacovigilance: a multicenter study from Khyber Pakhtunkhwa, Pakistan.
Sharif MJH; Farrukh MJ; Khan FU; Khan Q; Ahmed SS; Kousar R; Ahmad T; Abid SMA; Ashfaq M; Khan SA
Curr Med Res Opin; 2022 Apr; 38(4):595-605. PubMed ID: 35166143
[TBL] [Abstract][Full Text] [Related]
3. Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey.
Dorji C; Tragulpiankit P; Riewpaiboon A; Tobgay T
Drug Saf; 2016 Dec; 39(12):1239-1250. PubMed ID: 27743333
[TBL] [Abstract][Full Text] [Related]
4. Adverse Drug Reaction Monitoring and Reporting Among Physicians and Pharmacists in Pakistan: A Cross-sectional Study.
Nisa ZU; Zafar A; Zafar F; Pezaro S; Sher F
Curr Drug Saf; 2020; 15(2):137-146. PubMed ID: 32338223
[TBL] [Abstract][Full Text] [Related]
5. Optimizing spontaneous adverse drug reaction reporting in public healthcare setting in Namibia.
Adenuga BA; Kibuule D; Rennie TW
Basic Clin Pharmacol Toxicol; 2020 Mar; 126(3):247-253. PubMed ID: 31520574
[TBL] [Abstract][Full Text] [Related]
6. Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria.
Adisa R; Omitogun TI
BMC Health Serv Res; 2019 Dec; 19(1):926. PubMed ID: 31796034
[TBL] [Abstract][Full Text] [Related]
7. Healthcare professionals' knowledge, attitude and practice towards adverse drug reaction (ADR) reporting at the health center level in Ethiopia.
Seid MA; Kasahun AE; Mante BM; Gebremariam SN
Int J Clin Pharm; 2018 Aug; 40(4):895-902. PubMed ID: 30094559
[TBL] [Abstract][Full Text] [Related]
8. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.
Ali MD; Hassan YA; Ahmad A; Alaqel O; Al-Harbi H; Al-Suhaimi NM
Curr Drug Saf; 2018; 13(1):21-25. PubMed ID: 29256354
[TBL] [Abstract][Full Text] [Related]
9. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
Tandon VR; Mahajan V; Khajuria V; Gillani Z
Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
[TBL] [Abstract][Full Text] [Related]
10. Knowledge, attitude, practice and barriers towards pharmacovigilance and adverse drug reactions reporting among healthcare professionals in Turkey: a systematic review.
Khan Z; Karatas Y; Martins MAP; Jamshed S; Rahman H
Curr Med Res Opin; 2022 Jan; 38(1):145-154. PubMed ID: 34694167
[TBL] [Abstract][Full Text] [Related]
11. Adverse drug reaction reporting practice and associated factors among medical doctors in government hospitals in Addis Ababa, Ethiopia.
Nadew SS; Beyene KG; Beza SW
PLoS One; 2020; 15(1):e0227712. PubMed ID: 31961883
[TBL] [Abstract][Full Text] [Related]
12. Attitudes among healthcare professionals to the reporting of adverse drug reactions in Nepal.
Santosh KC; Tragulpiankit P; Gorsanan S; Edwards IR
BMC Pharmacol Toxicol; 2013 Mar; 14():16. PubMed ID: 23497690
[TBL] [Abstract][Full Text] [Related]
13. Community pharmacists' knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey.
Li R; Curtain C; Bereznicki L; Zaidi STR
Int J Clin Pharm; 2018 Aug; 40(4):878-889. PubMed ID: 30097819
[TBL] [Abstract][Full Text] [Related]
14. Exploring healthcare professionals' knowledge, attitude, and practices towards pharmacovigilance: a cross-sectional survey.
Hussain R; Hassali MA; Hashmi F; Akram T
J Pharm Policy Pract; 2021 Jan; 14(1):5. PubMed ID: 33397478
[TBL] [Abstract][Full Text] [Related]
15. Barriers and facilitators to pharmacovigilance activities in Pakistan: A healthcare professionals-based survey.
Hussain R; Akram T; Hassali MA; Muneswarao J; Rehman AU; Hashmi F; Babar ZU
PLoS One; 2022; 17(7):e0271587. PubMed ID: 35905133
[TBL] [Abstract][Full Text] [Related]
16. Knowledge of Adverse Drug Reaction Reporting and the Pharmacovigilance of Biological Medicines: A Survey of Healthcare Professionals in Ireland.
O'Callaghan J; Griffin BT; Morris JM; Bermingham M
BioDrugs; 2018 Jun; 32(3):267-280. PubMed ID: 29721705
[TBL] [Abstract][Full Text] [Related]
17. Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation.
Aziz AA; Rogers S; Hassanien O; Shalaby L; Nagy M
Per Med; 2022 Nov; 19(6):495-507. PubMed ID: 36239598
[TBL] [Abstract][Full Text] [Related]
18. An observational study to compare the contents and quality of information furnished in CDSCO ADR reporting form, yellow card, medwatch and blue form by the healthcare professionals.
Rehan HS; Chopra D; Holani SN; Mishra R
Int J Risk Saf Med; 2014; 26(1):1-8. PubMed ID: 24796346
[TBL] [Abstract][Full Text] [Related]
19. Awareness, knowledge, and attitude toward adverse drug reaction (ADR) reporting among healthcare professionals in Ghana.
Yawson AA; Abekah-Nkrumah G; Okai GA; Ofori CG
Ther Adv Drug Saf; 2022; 13():20420986221116468. PubMed ID: 35966898
[TBL] [Abstract][Full Text] [Related]
20. Adverse drug reaction reporting among health care workers at Mulago National Referral and Teaching hospital in Uganda.
Katusiime B; Semakula D; Lubinga SJ
Afr Health Sci; 2015 Dec; 15(4):1308-17. PubMed ID: 26958036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
